
Invitae Corporation NVTA
Quartalsbericht 2023-Q3
hinzugefügt 08.11.2023
Invitae Corporation EV 2011-2026 | NVTA
EV Jährlich Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.11 B | 3.39 B | 7.99 B | 2.03 B | 943 M | 403 M | 240 M | 143 M | 105 M | 47.3 M | 38.7 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.99 B | 38.7 M | 1.58 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
-1.92 M | $ 1.61 | -2.73 % | $ 2.14 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
45.8 B | $ 115.01 | -0.53 % | $ 35 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Illumina
ILMN
|
15.3 B | $ 126.74 | -1.39 % | $ 20.2 B | ||
|
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 24.61 | -1.48 % | $ 684 M | ||
|
Lantheus Holdings
LNTH
|
5.9 B | $ 83.13 | -1.17 % | $ 5.61 B | ||
|
Check-Cap Ltd.
CHEK
|
2.55 M | - | - | $ 9.42 M | ||
|
National Research Corporation
NRC
|
432 M | $ 16.99 | -0.7 % | $ 380 M | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
1.04 B | $ 21.87 | 0.07 % | $ 1.17 B | ||
|
Koninklijke Philips N.V.
PHG
|
13.2 B | $ 27.1 | -1.6 % | $ 20 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Precipio
PRPO
|
42.5 M | $ 30.2 | -2.6 % | $ 48.5 M | ||
|
Personalis
PSNL
|
229 M | $ 5.48 | -8.07 % | $ 325 M | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
Senseonics Holdings
SENS
|
376 M | $ 7.26 | -0.21 % | $ 303 M | ||
|
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 15.27 | -2.12 % | $ 462 M | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Thermo Fisher Scientific
TMO
|
186 B | $ 469.06 | 0.22 % | $ 177 B | ||
|
Charles River Laboratories International
CRL
|
11.4 B | $ 167.26 | -2.32 % | $ 8.29 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 0.63 | -2.27 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 59.48 | -2.49 % | $ 3.56 B | ||
|
Guardant Health
GH
|
15.2 B | $ 82.6 | -6.67 % | $ 10.4 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
16.3 M | $ 1.93 | - | $ 8.54 M | ||
|
Medpace Holdings
MEDP
|
14 B | $ 417.3 | -0.97 % | $ 12 B | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
6.63 M | $ 2.15 | -1.38 % | $ 4.94 M | ||
|
ICON Public Limited Company
ICLR
|
26.4 B | $ 101.21 | -1.94 % | $ 8.35 B | ||
|
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 261.53 | -0.72 % | $ 21.8 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 9.18 | -2.86 % | $ 1.99 B | ||
|
Celcuity
CELC
|
5.57 B | $ 122.61 | -2.44 % | $ 5.73 B | ||
|
NeoGenomics
NEO
|
1.85 B | $ 8.69 | 0.93 % | $ 1.11 B | ||
|
Myriad Genetics
MYGN
|
598 M | $ 4.82 | -0.31 % | $ 446 M | ||
|
Natera
NTRA
|
5.53 B | $ 199.52 | -2.38 % | $ 19.6 B | ||
|
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 196.26 | -0.19 % | $ 21.8 B | ||
|
OpGen
OPGN
|
10.3 M | - | -16.95 % | $ 1.54 M |